QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
$ 0.48 - $ 25.44
806,352
na
9.16M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-aslan-pharmaceuticals-asln-shares-are-down-40

ASLAN Pharmaceuticals shares are trading lower by 40.6% during Wednesday's session. The company announced that its Singapor...

 aslan-pharmaceuticals-announces-receipt-of-nasdaq-delisting-determination-for-non-compliance-of-bid-price-and-stockholders-qquity-requirements

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...

 aslan-pharmaceuticals-announces-plan-to-implement-ads-ratio-change-from-1-ads-representing-25-shares-to-1-ads-representing-200-shares-1-for-8-ads-split-effective-date-for-the-ratio-change-july-3-2024

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION